Ow-grade spindle cell neoplasm of myofibroblastic origin. What is it
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Understanding "Low-Grade Spindle Cell Neoplasm of Myofibroblastic Origin"
I appreciate you sharing this medical terminology with me. However, I need to be direct with you: this diagnosis description does not match DCIS (Ductal Carcinoma In Situ) of the breast, which is what your [ID removed] you have.
This term describes a completely different type of tumor that:
- Originates from myofibroblasts (a specific type of muscle-like cell)
- Is typically found in soft tissues (not breast tissue)
- Is a "spindle cell" tumor (cells that look elongated under the microscope)
- Is classified as "low-grade" (slower-growing)
Why This Matters
This type of diagnosis would typically be seen in:
- Soft tissue sarcomas (cancers of connective tissue)
- Benign or low-grade tumors of muscles, tendons, or fascia
- Conditions completely different from breast cancer
What You Should Do
This is important: There may be a mix-up with your [ID removed] or terminology. I strongly recommend:
-
Contact your oncology team directly and ask them to clarify:
- "Can you explain my exact diagnosis in simple terms?"
- "Is this related to my breast cancer, or is this a separate finding?"
- "What tissue did this tumor come from?"
-
Request a copy of your pathology report (the detailed lab analysis of your tumor)
-
Ask for clarification on your cancer type - whether it's truly DCIS or something else
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Related Services
Services that may help with diagnosis for Breast - DCIS patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: